The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients with Treatment-refractory Infections

Francesco P. Tambaro, Dristhi Ragoonanan, Priti Tewari, Demetrios Petropoulos, Fleur M. Aung, Kris M. Mahadeo, Sajad Khazal

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

While advancements in cellular therapy have improved outcomes for patients with refractory leukemia, severe infections may hinder access. Granulocyte transfusions, in combination with anti-microbial therapy, may be a safe option to facilitate candidacy for chimeric antigen receptor T-cell therapy in patients with leukemia and prolonged immune-compromised status.

Original languageEnglish (US)
Pages (from-to)E463-E466
JournalJournal of Pediatric Hematology/Oncology
Volume44
Issue number2
DOIs
StatePublished - Mar 1 2022

Keywords

  • acute lymphoblastic leukemia
  • chimeric antigen receptor T-cell therapy
  • granulocyte transfusions

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients with Treatment-refractory Infections'. Together they form a unique fingerprint.

Cite this